抄録
Recent electrophysiological studies have clarified that endogenous cannabinoids (endocannabinoids) mediate retrograde signals from postsynaptic neurons to presynaptic terminals in the CNS. Endocannabinoids can be released from postsynaptic neurons following depolarization-induced elevation of intracellular Ca2+ concentration. The released endocannabinoids act retrogradely onto presynaptic cannabinoid CB1 receptors and suppress inhibitory or excitatory neurotransmitter release. This type of modulation has been termed depolarization-induced suppression of inhibition (DSI) or excitation (DSE). Endocannabinoid release and resultant retrograde suppression of transmitter release are also triggered by activation of group I metabotrophic glutamate receptors (mGluRs) or muscarinic acetylcholine receptors (mAChRs) in the postsynaptic neurons. This pathway can work independently of the depolarization-induced mechanism, because group I mGluR activation can produce endocannabinoids when the postsynaptic neuron is loaded with the fast Ca2+ buffer BAPTA. Nevertheless, evidence suggests that these two pathways for endocannabinoid production can work cooperatively in neurons. It is shown that DSI is enhanced significantly when group I mGluRs, or mAChRs is activated simultaneously by its specific agonists. This enhancement is much more prominent than what is expected from the simple summation of depolarization-induced and group I mGluR/mAChR-induced endocannabinoid release. Activation of group I mGluRs or mAChRs causes no significant change in depolarization-induced Ca2+ transients, indicating that the enhanced DSI does not result from the augmentation of Ca2+ influx. The CB1, group I mGluRs, mAChRs and voltage-gated Ca2+ channels are all expressed widely in the CNS. Thus, the endocannabinoid-mediated retrograde modulation is an important and widespread mechanism for the regulation of synaptic transmission in the CNS.
本文言語 | 英語 |
---|---|
ページ(範囲) | 49-57 |
ページ数 | 9 |
ジャーナル | Current Neuropharmacology |
巻 | 2 |
号 | 1 |
DOI | |
出版ステータス | 出版済み - 2004/01 |
ASJC Scopus 主題領域
- 薬理学
- 神経学
- 臨床神経学
- 精神医学および精神衛生
- 薬理学(医学)